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ABSTRACTSover 1 year (April 2010-2011) with a historic cohort from 5 years earlier
(April 2005-2006).
Results: 2010/11 - 114 patients, 2005/6 - 133 patients. No change in propor-
tion of emergency presentations - 21.2% in 2010/2011 versus 25.6% in 2005/6
(p¼0.6044).A signiﬁcant reduction in stage - 45%DukesC/D compared to 64%
in historic cohort (p¼0.0038).More right sided CRCs presenting - 39.5% 2010/
11 versus 33.8% 2005/6 (p¼0.36). Greater proportionpresentedwith anaemia
(23.7% versus 14.3%, p¼0.0586). Duration of anaemia prior to presentation
increased (365 days versus 150 days, p¼0.292).
Conclusion: Since BCSP introduction there has been a signiﬁcant decrease
in stage of CRC at presentation but no decrease in emergency presenta-
tions. There has been a shift towards more right sided tumours which may
explain the trend to an increase in those presenting with anaemia.
0935: LOOP ILEOSTOMY REVERSAL: 5 YEAR EXPERIENCE IN AN
ENGLISH RURAL DISTRICT GENERAL HOSPITAL
Dhya Al-Leswas, Magdalena Oles, Daniel Negrea, Milind Rao. Pilgrim
Hospital, Boston, Lincolnshire, UK
Introduction: Loop ileostomy(LI) is fashioned to protect against the
substantial risk of leakage from low pelvic anastomosis. However, the
revision of these LIs has a reported morbidity of 5.7-69%.
Aim: To report the outcome of reversal LI in a rural district general
hospital(DGH).
Method: Retrospective data collection and analysis for patients who
underwent reversal LI between November 2006 and October 2011.
Results: Sixty-nine patients (45M,24F) with amedian age of 69(23-87) and
mean BMI of 26.8+/-5.3 had a reversal of defunctioning LI for: i) 38 rectal
and 10 colonic cancers; ii) 9 inﬂammatory bowel and 4 diverticular
diseases; and iii) 8 other. Anastomotic technique was hand sewn in
44(63.8%) and stapled closure in 25(36.2%). The mean periods for light diet
tolerance and bowel movement were 2.9+/-1.8 and 3.5+/- 2.1days,
respectively. The overall morbidity and mortality were 15(21.7%) and
2(2.9%), respectively. Six(8.7%) patients had septic complications and
9(13%) had small bowel obstruction(SBO). The mean in-patient stay was
7.9+/-7.5 days. Around 6% of the patients have been re-admitted within 90
days of the procedure with subacute SBO.
Conclusions: Overall outcomes are comparable with tertiary centres.
However this study again highlights the high morbidity associated with
the procedure and senior presence at the time of surgery may help.
0958: A REVIEW OF PATIENTS IN A SINGLE CENTRE WITH ILEAL POUCH-
ANAL ANASTOMOSIS FOR ULCERATIVE COLITIS AND AN ASSESSMENT
OF THOSE PATIENTS WHO REQUIRE ON GOING MEDICAL THERAPY
Natalie Allen, Eunice Garforth, Richard Heath, Paul Rooney. The Royal
Liverpool and Broadgreen University Teaching Hospitals, Mersey, UK
Aims:Restorative proctocolectomywith ileal pouch-anal anastomosis(IPAA)
is the surgical therapy of choice for patients with chronic ulcerative colitis.
A proportion of patients require ongoing medical management, which this
study assesses.
Methods: A prospectively collected hospital database from a single centre
and a review of case-notes was completed, assessing surgery prior to IPAA
and post-operative complications. An assessment was made of those who
were recommenced on medication.
Results: 102 patients’ were included,(60 male:42 female, mean age 42
years Standard Deviation of+-12.01). Follow-up is ongoing and currently
between 2 and 193 months. Complications included anastomotic
leak(n¼4), incisional hernia(n¼7), pouchitis(n¼36), stenosis(n¼15), pre
pouch stricture(n¼ 1), ileitis(n¼2), enterocutaneous ﬁstula(n¼2), peri-
anal ﬁstula(n¼6), pouch vaginal ﬁstula(n¼5), pouch ulceration(n¼8). All
patients prior to surgery had a histological diagnosis of UC, 4 patients
were reclassiﬁed as Crohn's. 13(12.7%)patients were recommenced on
medication, including sulphasalazine, budesonide, azathioprine, 6-
mercaptopurine and inﬂiximab. All patients reclassiﬁed as Crohn's were
recommenced on medication and seen in a joint gastro/surgical clinic.
Conclusions: Long-term anastomotic problems are common after IPPA.
Most patients don't require additional medication other than antibiotics
but 12.7% need continued complex medical therapy under the care of
gastroenterologists and surgeons. Use of steroids is low. Diagnostic prob-
lems remain an issue.1002: THE RELATIONSHIP BETWEEN CIRCULATORY AND TUMOUR CRP,
PAKT, MAPK AND SURVIVAL IN PATIENTS UNDERGOING POTENTIALLY
CURATIVE ELECTIVE RESECTION FOR COLORECTAL CANCER
Arfon Powell, Scott Shepherd, Donald McMillan, Paul Horgan, Joanne
Edwards. University of Glasgow, Glasgow, UK
Introduction: CRP is associated with activation of PI3K/Akt, MAPK,
increased tumour cell proliferation and inhibition of apoptosis. This study
examined the relationship between circulatory and tumour CRP, pAkt,
MAPK and survival in patients undergoing potentially curative elective
resection for colorectal cancer.
Methods: Tumours from 147 patients with CRC had immunohistochemical
analysis for CRP, MAPK and pAkt performed.
Results: Nuclear(n) CRP correlated with advanced T stage (P¼0.022) and
cytoplasmic(c) CRP correlated with necrosis (P¼0.028). npAkt correlated
with higher LNR (P¼0.027). There were no signiﬁcant relationships
between survival pathways. Minimum follow-up was 120 months with 41
cancer deaths. On multivariate analysis of all signiﬁcant clinicopatholog-
ical factors, LNR (P<0.001), Peterson Index (P<0.001), Klintrup score
(P¼0.017) and systemic(s) CRP (P<0.001) were independently related to
cancer-speciﬁc survival. sCRP (P¼0.007) was only signiﬁcant in right sided
tumours with cCRP (P¼0.022) signiﬁcant in left sided tumours. cpAkt
(P¼0.029) was signiﬁcant in rectal tumours.
Conclusion: This study did not elicit any link between the systemic
inﬂammatory response and activation of pAkt and MAPK. These ﬁndings
support the concept of colorectal tumour heterogeneity with different
methods of invasion and metastasis. Understanding the mechanisms by
which tumours from each genetic pathway progress and metastasis will
help develop personalised treatment regimens.
1030: NEOADJUVANT CHEMO-RADIOTHERAPY AND LYMPH NODE
RETRIEVAL RATES AFTER CURATIVE RESECTION FOR RECTAL
CANCERS- SHOULD THE SAME STANDARDS APPLY?
Philip Varghese, Zakir Mohamed, Fadlo Shaban, Talvinder
Gill, Mohammed Tabaqchali, Dharmendra Garg, David Borowski, Anil
Agarwal. University Hospital of North Tees, Stockton-on-Tees, UK
Aims: This study aimed to evaluate if there is a signiﬁcant difference in the
number of lymph nodes(LN) harvested following neoadjuvant chemo-
radiotherapy(N-CRT) and resection vs. curative resection only.
Methods: A retrospective review of a prospectively collected data of
patients who underwent curative resection for rectal cancers between
2008-2011 was carried out. LN yield was compared in the two groups with
respect to the tumour stage, type of surgical resection, location of tumour
and response to treatment on imaging and ﬁnal histology.
Results: 138 patients with rectal cancer were identiﬁed; 71 N-CRT
group(A) and 67 in the primary resection group(B). The mean age at
treatment was 65.7 yrs(A) and 67.8yrs(B), male:female ratio of 2:1 in both
groups. The groups were well matched. There were more patients with
fewer than 12 LN in group-A (28 vs.22); however this was not statistically
signiﬁcant (p>0.05). No signiﬁcant correlation between LN yield vs. tumor
stage and type of resection was seen. Tumour response to N-CRT on MRI
and histology showed no signiﬁcant difference in LN yield in the good,
partial and no response group (p>0.05).
Conclusions: N-CRT for rectal cancer did not result in any signiﬁcant
reduction in LN yield. We recommend continuing use of AJCC-TNM stan-
dard of minimum 12 for accurate nodal staging.
1088: DOES CONVERSION ALTER OUTCOME IN LAPAROSCOPIC
COLORECTAL SURGERY?
Nigel Rajaretnam, Gregory Nason, Brian Barry, Paul Neary. Adelaide and
Meath incorporating the National Children's Hospital, Tallaght, Dublin, Ireland
Introduction: Laparoscopic Colorectal surgery has been shown by some
trials to confer a survival advantage to patients. Controversy exists on the
impact of converting laparoscopic cases to open in terms of increasing
morbidity and impairing cancer related survival. We assessed whether
conversion to open surgery had long term implications.
Methods: We performed a retrospective analysis of our prospective
database for all patients undergoing colorectal cancer surgery from
January 2005 to April 2008. Disease related and overall mortality rates
were cross referenced with the National Cancer Registry of Ireland.
Abstracts / International Journal of Surgery 10 (2012) S1–S52 S31
ABSTRACTSResults: 279 patients underwent surgery for colorectal cancer during this
period.80.3% were laparoscopic and 19.7% open. The conversion rate was
13.8% (Inter-surgeon range 11-17%). The median follow up was 50 months.
The overall mortality rate was 17.9%. Patients that had undergone lapa-
roscopic surgery for colorectal cancer had a signiﬁcant difference in their
overall mortality rate over those that were converted (14.5% v's 32.2%;
p¼0.02). For disease speciﬁc related mortality laparoscopic surgery
resulted in less mortality than open for non metastatic disease (AJCC Stage
I, II; 5.2% v's 17.9%; p¼0.04).
Conclusions: In summary, overall mortality and disease speciﬁc survival is
worse after conversion. Laparoscopic colorectal cancer surgery should only
be undertaken by speciﬁc surgeons in specialised MIS units with low
conversion rates.
1151: SHORT TERM OUTCOMES IN LAPAROSCOPIC VERSUS OPEN
APPROACH IN LEFT AND RIGHT HEMICOLECTOMIES WITHIN AN
ENHANCED RECOVERY PROGRAMME
Kam Wa Jessica Mok, Zia Moinuddin, Lyndon Jones. Royal Blackburn
Hospital, Blackburn, UK
Short term outcome beneﬁts in laparoscopic colectomies remains
debatable. We compared the short-term outcomes between
laparoscopic and open surgery and compared these with left and right
hemicolectomies.
Data was collected from enhanced recovery programme database between
2009 and 2011. 61 patients underwent left hemicolectomy (laparoscopic to
open ratio, 2:3) and 102 had right hemicolectomy (laparoscopic to open
ratio, 5:8). Short term and postoperative outcomes were compared.
Hospital staywas shorter in the laparoscopic groupcompared toopen inboth
left hemicolectomy (7 days compared to 9, p¼<0.03) and right hemi-
colectomy (6 compared to7.5days, p< 0.02). Complication rateswerehigher
amongst patient who underwent open surgery for left hemicolectomies
(complication rate of laparoscopic versus open ¼29.17% versus 51.35%).
However there were no differences in complication rates when comparing
the two approaches in right hemicolectomies. Rate of ileus was higher in
patients who had open left hemicolectomies, but there was no difference in
rate of ileus amongst right hemicolectomy open or laparsocopic approach.
Laparoscopic colorectal surgery reduces length of hospital stay in both left
and right hemicolectomies. It is also associated with lower morbidity in
patients undergoing left hemicolectomies but does not improve morbidity
in patients undergoing right hemicolectomies.
1165: OPTIMIZATION OF PERI-OPERATIVE HDU CARE FOR ELECTIVE
COLORECTAL PATIENTS
Khurram Siddique, Raza Cheema, Promad Bapat, Liviu Titu. Wirral
University Hospitals NHS Trust, Wirral, UK
Objectives: To review the care of high-risk elective colorectal patients with
regards to timing of discharge from the HDU & its effects on post-op
complications, re-admission to HDU, length of stay (LOS) and mortality.
Methods: All elective colorectal patients admitted to HDU during 2010
were included. Patients were divided into two groups with regards to their
stay on HDU: Group1 < 48 hrs & Group2 >48 hrs. Data regarding demo-
graphics, post-op complications, re-admission & mortality were collected
& analysed using SPSS version 14.
Results:Out of the total of 40 patients, 21 were females with a median age
of 74 (range 45-92). The number of patients in group 1 & 2 were 26 and 14
respectively. Laparoscopic procedures were performed in 31 patients.
Post-op complications were higher (72.2% Vs 27.8%, p<0.04) & length of
stay was signiﬁcantly longer [8 (IQR 4-41) Vs 6.5(4-12) p<0.03)]; amongst
group 1 than group 2 patients. Four patients in group 1 were re-admitted
to HDU. No mortality was reported.
Conclusion: Early discharge from the HDU is associated with a signiﬁcant
risk of complications; re-admission (15.3%) and a prolonged length of stay.
Ensuring a minimum stay of 48 hrs would reduce morbidity thus opti-
mizing HDU patient care.
1194: METABOLIC EFFECTS OF CHEMORADIOTHERAPY IN RECTAL
CANCER PATIENTS
Maryam Alfa-wali 1, Diana Tait 2, Hector Keun 1, Anthony
Antoniou 1. 1 Imperial College, London, UK; 2Royal Marsden NHS
Foundation Trust, London, UKAim:Neo-adjuvant chemoradiotherapy is part of the standard treatment of
care for down staging rectal cancers prior to surgery. However, the exact
impact of treatment response is a challenge to predict, with toxicity of
treatment being an added complication. The aim of the study was
to investigate themetabolic alterations of rectal cancer patients undergoing
therapy using proton nuclear magnetic resonance spectroscopy (1H NMR).
Methods: Twenty-four specimens were obtained from patients with rectal
cancer and controls. Plasma samples were used for the 1H NMR experi-
ments. All 1H NMR spectra were acquired using a Bruker DRX600C spec-
trometer (Bruker, Germany). Pattern recognition and statistical analysis
were performed using MATLAB and SIMCA software.
Results: Higher levels in lactate and choline metabolites were seen in,
rectal cancer patients undergoing chemoradiotherapy compared to
controls. Statistically signiﬁcant changes between the groups were also
observed in low-density lipoproteins, glycoproteins and amino acids such
as valine and glutamine.
Conclusion: Lipids in the form of phospholipids for cell membrane
synthesis were found to account for the distinct separation of samples
based on response to chemoradiotherapy. Although in its infancy, meta-
bolic proﬁling may in the future be used to monitor response to chemo-
radiotherapy early and hence potentially avoid toxicity effects.ENDOCRINE SURGERY
0196: PARATHYROIDECOMY IN A DISTRICT GENERAL HOSPITAL:
OUTCOMES AND EVOLUTION IN THE ERA OF MINIMALLY INVASIVE
SURGERY
Sharath Paravastu, David Chadwick. Chesterﬁeld Royal Hospital,
Chesterﬁeld, UK
Aim: To determine the outcomes of bilateral neck exploration(BNE)
and uptake as well as outcomes of minimally invasive para-
thyroidectomy(MIP) for primary hyperparathyroidism in a district general
hospital(DGH).
Methods: Review of prospectively maintained database of a single
surgeons' practice for outcomes of BNE and MIP between August 1999 and
December 2010. Patients were considered 'cured' when serum calcium
levels remained normal for more than 6 months after surgery.
Results: 368 patients underwent parathyroidectomy; BNE(n¼314) and
MIP(n¼54). 92 patients underwent preoperative localisation; ultra-
sound(n¼92) and 99TC Sestamibi(MIBI) scan(n¼91). Localisation from
Ultrasound andMIBI was noted in 65%(n¼60) and 71%(n¼65) respectively;
however, concordance between the scans was noted in only 59%(n¼54).
Overall cure rate was 97%. Intention-to-treat analysis, based on preoper-
ative imaging showed cure rates of 96% with BNE and 98% with
MIP(p¼0.53); whereas, based on surgical approach, cure rates were 96.5%
with BNE and 96.3% with MIP(p¼1.0).
Conclusions: Satisfactory cure rates for parathyroidectomy could be ach-
ieved in a DGH. Preoperative localisation studies with ultrasound and MIBI
have a positive concordance rate in only 60% of those considered for MIP,
thereby limiting the use of MIP and reinforcing the role of BNE in this era of
minimally invasive surgery.
0239: IOPANOIC ACID IS SAFE AND EFFECTIVE AS A BRIDGE TO
SURGERY IN THYROTOXICOSIS
Suddendra Doddi, Christopher Buckle, Yazan Masannat, Narayana
Prasad, Abbi Lulsegged, Prakash Sinha. Princess Royal University Hospital,
Bromley, London, UK
Aim: To determine the efﬁcacy and safety of iopanoic acid (IA) in achieving
euthyroidism prior to total thyroidectomy in patients with thyrotoxicosis.
Methods: Between 2007 and 2010, 9 patients with thyrotoxicosis were
treated with IA prior to total thyroidectomy. Data regarding indications for
surgery, dose of IA and ﬁnal outcomes were collected.
Results: The age range of the patients was 22-65 years and mean was 38
years. All were females. The indications for surgery were as follows:
allergic reaction to carbimazole(6 patients), neutropenia (1), propylth-
iouracil induced hepatotoxicity (1) and non-compliance with antithyroid
drugs(1). The mean total dose of IA was 7.7 gm; the range being 4.4 to 10.5
gm. The mean total duration was 4 days. In 8 patients IA was used alone
and in one patient it was used in combination with carbimazole. All ach-
ieved biochemical euthyroidism prior to surgery. Before and after the
